AI is a major driver of investment in digital health and life sciences companies, comprising nearly half of all investment activity. Smart healthcare founders and investors have their eye on …
Health
-
-
Treatment for dermatomyositis has not changed in decades, which makes a new FDA approval particularly meaningful for patients who have this rare immuinological disease affecting the skin and muscles. The …
-
More than a dozen health systems are warning patients this week of a phishing campaign impersonating Epic‘s MyChart patient portal. The scam emails use the MyChart logo and dangle fake …
-
Consider this: a condition that affects nearly one in three people with diabetes over their lifetime, carries a five-year mortality rate rivaling many cancers, and drives more than 85% of …
-
Pancreatic cancer, one of the most difficult to treat and deadliest malignancies, now has a new FDA-approved therapy that helps patients live longer, a first-in-class Revolution Medicines drug that blocks …
-
Sepsis can happen to anyone. Clinicians know it and patients fear it. But too few researchers target it. We’ve seen an upwell of news articles and social media posts about …
-
There’s one FDA-approved biologic drug for the immunological disorder eosinophilic esophagitis, or EoE. An AstraZeneca and Amgen antibody is bolstering its case to become a competitive alternative. This drug, Tezspire, …
-
Healthcare providers have more ways than ever to exchange health data, but getting medical records from another provider often still means relying on fax machines, emails, phone calls, and manual …
-
The rise of the consumer in healthcare is the theme of the INVEST Digital Health conference, scheduled for October 29 at Pegasus Park in Dallas, and in partnership with Health …
-
Medical device giant Boston Scientific has disclosed a cyberattack that it says is disrupting its IT systems and business applications across the globe. Below are seven things to know about …